Safety of sublingual-swallow immunotherapy in children and adults

International Archives of Allergy and Immunology

Volumn 121, Issue 3, 2000, Pages 229-234

  André, Claude ^a   Vatrinet, C ^a   Galvain, S ^a   Carat, F ^a   Sicard, H ^a  

^a Stallergenes SA   (France)

Author keywords

Asthma; Immunotherapy, sublingual swallow; Mites; Pollen; Rhinoconjunctivitis

Indexed keywords

ALLERGEN;

ADOLESCENT; ADULT; ALLERGIC DISEASE; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FRANCE; GASTROINTESTINAL SYMPTOM; GRASS POLLEN; GREECE; HEADACHE; HUMAN; IMMUNOTHERAPY; ITALY; LARYNX EDEMA; MAJOR CLINICAL STUDY; META ANALYSIS; MOUTH CAVITY; MULTICENTER STUDY; MUSCLE SPASM; POLLEN; PRIORITY JOURNAL; RHINITIS; RHINOCONJUNCTIVITIS; ULCER; WHEEZING;

EID: 0034112050     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024322     Document Type: Article

References (23)

1. Malling H-J: Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53:461-472.
2. Committee on Safety of Medicines Update: Desensitizing vaccines. Br Med J 1986;293:948.
3. Malling H-J, Weeke B: Position paper. Immunotherapy. Allergy 1993;48(suppl 14):9-35.
4. Feliziani V, Lattuada S, Parmioni S, Dall'Aglio PP: Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995;23:224-230.
5. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H: A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309-313.
6. Tari MG, Mancino M, Monti G: Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990;18:277-284.
7. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC: Sublingual immunotherapy in Parietaria pollen-induced rhinitis: A double-blind study. J Investig Allergol Clin Immunol 1995;5:25-30.
8. Bousquet J, Lockey RF, Malling H-J: WHO position paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 1998;53(suppl 44):1-42.
9. Clavel R, Bousquet J, André C: Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493-498.
10. Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, André C, Papageorgiou PS: Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662-672.
11. Bousquet J, Scheinmann P, Guinnepain M-T, Perrin-Fayolle M, Sauvaget J, Tonnel AB, Pauli G, Caillaud D, Dubost R, Leynadier F, Vervloet D, Herman D, Galvain S, André C: Sublingual-swallow immunotherapy in patients with asthma due to house dust mites: A double-blind placebo-controlled study. Allergy 1999;54:249-250.
12. Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, André C: Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999;54:819-828.
13. La Rosa M, Ranno C, André C, Carat F, Tosca MA, Canonica GW: Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425-432.
14. Guez S, Vatrinet C, Fadel R, André C: House dust mite sublingual-swallow immunotherapy in perennial rhinitis. A double-blind placebo-controlled study. Allergy, in press.
15. André C, Perrin-Fayolle M, Grosclaude M, Couturier P, Basset D, Cornillon J, Piperno D, Girodet B, Sanchez R, Vallon C, Bellier P, Nasr M: Ragweed sublingual-swallow immunotherapy in rhinoconjunctivitis and asthma. In preparation.
16. Edwards AM, André C, Fadel R, Sicard H, Vatrinet C, Galvain S, Carat F: Efficacy of sublingual-swallow immunotherapy using standardised allergen extracts (Stallergènes) of inhaled allergens. Allergy 1998;53:169.
17. André C, Vatrinet C, Galvain S, Carat F, Sicard H: Safety of sublingual-swallow immunotherapy using Stallergènes extracts in children and adults. Allergy 1998;53:116-117.
18. White P, Smith H, Baker N, Davis W, Frew A: Symptom control in patients with hay fever in UK general practice: How well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 1998;28:266-270.
19. Hirsch T, Sähn M, Leupold W: Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8:21-27.
20. Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela G-S, Canonica G-W: Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629-632.
21. Hordijk GJ, Antvelink JB, Luwema RA: Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Allergol Immunopathol (Madr) 1998;26:234-240.
22. Horak F, Stübner P, Berger UE, Marks B, Toth J, Jäger S: Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. J Investig Allergol Clin Immunol 1998;8:165-171.
23. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW: Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-1113.